|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.265 SEK | -1.49% |
|
-4.46% | +10.89% |
| 07-08 | Mendus Completes First Stage Recruitment for Vididencel Trial | MT |
| 07-08 | Mendus completes recruitment for the first part of the VITAL-CML study | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 40.3M | - | ||||
| 50.61B | |||||
| 39.11B | - | - | - | - | - |
| 34.64B | |||||
| 33.79B | |||||
| 26.89B |
- Stock Market
- Stocks
- IMMU Stock
- Charts Mendus AB
- Sector Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
